![Daniel S. Gold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel S. Gold
Nessuna posizione attualmente
Profilo
Daniel S.
Gold worked as a Director at Absci Corp., a Group Leader at Genentech, Inc., a Senior VP of Manufacturing & Pharmaceutical Operations at Human Genome Sciences, Inc., a Senior Scientist at Genencor International, Inc., the President & COO at Sutro Biopharma, Inc., the VP of Process Development at Khepri Pharmaceuticals, Inc., and the Chief Scientific Officer & VP of Process Development at Diosynth RTP, Inc. Gold received his undergraduate and doctorate degrees from Massachusetts Institute of Technology and his undergraduate degree from Tufts University.
Precedenti posizioni note di Daniel S. Gold
Società | Posizione | Fine |
---|---|---|
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
ABSCI CORPORATION | Direttore/Membro del Consiglio | - |
Khepri Pharmaceuticals, Inc.
![]() Khepri Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million. | Corporate Officer/Principal | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Genencor International, Inc.
![]() Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Corporate Officer/Principal | - |
Formazione di Daniel S. Gold
Tufts University | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SUTRO BIOPHARMA, INC. | Health Technology |
ABSCI CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
Diosynth RTP, Inc.
![]() Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Health Technology |
Genencor International, Inc.
![]() Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Khepri Pharmaceuticals, Inc.
![]() Khepri Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million. | Commercial Services |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
- Borsa valori
- Insiders
- Daniel S. Gold